Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000120600 | SCV000701762 | benign | not specified | 2016-10-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002312540 | SCV000846792 | benign | Inborn genetic diseases | 2016-06-06 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV000877781 | SCV001020567 | benign | Rubinstein-Taybi syndrome | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001682831 | SCV001896485 | benign | not provided | 2020-02-19 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001682831 | SCV004141000 | benign | not provided | 2022-09-01 | criteria provided, single submitter | clinical testing | CREBBP: BS1, BS2 |
ITMI | RCV000120600 | SCV000084758 | not provided | not specified | 2013-09-19 | no assertion provided | reference population |